{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:43Z","timestamp":1794020023420,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T00:00:00Z","timestamp":1324684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11926-011-0231-5","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T12:34:37Z","timestamp":1324643677000},"page":"189-194","source":"Crossref","is-referenced-by-count":68,"title":["Update on the Phenotypic Spectrum of Lesch-Nyhan Disease and its Attenuated Variants"],"prefix":"10.1007","volume":"14","author":[{"given":"Rosa J.","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. A.","family":"Jinnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,24]]},"reference":[{"key":"231_CR1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-2-48","volume":"2","author":"RJ Torres","year":"2007","unstructured":"Torres RJ, Puig JG. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis. 2007;2:48.","journal-title":"Orphanet J Rare Dis"},{"key":"231_CR2","first-page":"2537","volume-title":"The metabolic and molecular bases of inherited disease","author":"HA Jinnah","year":"2001","unstructured":"Jinnah HA, Friedmann T. Lesch-Nyhan disease and its variants. In: Scriver CR et al., editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p. 2537\u201370."},{"key":"231_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(64)90104-4","volume":"36","author":"M Lesch","year":"1964","unstructured":"Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med. 1964;36:561\u201370.","journal-title":"Am J Med"},{"key":"231_CR4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0165-0173(99)00094-6","volume":"32","author":"JE Visser","year":"2000","unstructured":"Visser JE, Baer PR, Jinnah HA. Lesch-Nyhan syndrome and the basal ganglia. Brain Res Rev. 2000;32:449\u201375.","journal-title":"Brain Res Rev"},{"key":"231_CR5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/brain\/awl056","volume":"129","author":"HA Jinnah","year":"2006","unstructured":"Jinnah HA, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain. 2006;129:1201\u201317.","journal-title":"Brain"},{"key":"231_CR6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1017\/S135561770177703X","volume":"7","author":"DS Schretlen","year":"2001","unstructured":"Schretlen DS, et al. Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency. J Int Neuropsychol Soc. 2001;7:805\u201312.","journal-title":"J Int Neuropsychol Soc"},{"key":"231_CR7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.156.3778.1122","volume":"156","author":"ME Balis","year":"1967","unstructured":"Balis ME, et al. Urinary metabolites in congenital hyperuricosuria. Science. 1967;156:1122\u20133.","journal-title":"Science"},{"key":"231_CR8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/215859a0","volume":"215","author":"L Sweetman","year":"1967","unstructured":"Sweetman L, Nyhan WL. Excretion of hypoxanthine and xanthine in a genetic disease of purine metabolism. Nature. 1967;215:859\u201360.","journal-title":"Nature"},{"key":"231_CR9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3476(68)80274-4","volume":"73","author":"JM Kaufman","year":"1968","unstructured":"Kaufman JM, Greene ML, Seegmiller JE. Urine uric acid to creatinine ratio\u2014a screening test for inherited disorders of purine metabolism. J Pediatr. 1968;73:583\u201392.","journal-title":"J Pediatr"},{"key":"231_CR10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awq013","volume":"133","author":"HA Jinnah","year":"2010","unstructured":"\u2022\u2022 Jinnah HA, et al. Attenuated variants of Lesch-Nyhan disease. Brain. 2010;133: 671\u201389. This is the largest and most comprehensive summary of LND variants published to date, with detailed information on the clinical phenotype and genetics. It questions the value of dividing the phenotype into two or three distinct patient subgroups and instead argues for a continuum of disease severity.","journal-title":"Brain"},{"key":"231_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005792-200103000-00003","volume":"80","author":"JG Puig","year":"2001","unstructured":"Puig JG, et al. The spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency: clinical experience based on 22 patients from 18 Spanish families. Medicine. 2001;80:102\u201312.","journal-title":"Medicine"},{"key":"231_CR12","first-page":"423","volume":"166","author":"BT Emmerson","year":"1973","unstructured":"Emmerson BT, Thompson L. The spectrum of hypoxanthine-guanine phosphoribosyltranferase deficiency. Q J Med. 1973;166:423\u201340.","journal-title":"Q J Med"},{"key":"231_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-70-1-155","volume":"70","author":"WN Kelley","year":"1969","unstructured":"Kelley WN, et al. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann Int Med. 1969;70:155\u2013206.","journal-title":"Ann Int Med"},{"key":"231_CR14","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1055\/s-0028-1114586","volume":"84","author":"W Catel","year":"1959","unstructured":"Catel W, Schmidt J. Uber familiare gichtische Diathese in Verbindung mit zerebralen und renalen Symptomen bei einem Kleinkind. Dtsch Med Wschr. 1959;84:2145\u20137.","journal-title":"Dtsch Med Wschr"},{"key":"231_CR15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1203\/00006450-197912000-00013","volume":"13","author":"B Bakay","year":"1979","unstructured":"Bakay B, et al. Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome. Pediatr Res. 1979;13:1365\u201370.","journal-title":"Pediatr Res"},{"key":"231_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4615-9140-5_52","volume":"122A","author":"B Bakay","year":"1980","unstructured":"Bakay B, et al. Variation in human HPRT and its relationship to neurologic and behavioral manifestations. Adv Exp Med Biol. 1980;122A:317\u201325.","journal-title":"Adv Exp Med Biol"},{"key":"231_CR17","first-page":"501","volume":"24","author":"J Marie","year":"1967","unstructured":"Marie J, Royer P, Rappaport R. Hyperuricemie congenitale avec troubles neurologiques, renaux et sanguins. Arch Fr Pediatr. 1967;24:501\u201310.","journal-title":"Arch Fr Pediatr"},{"key":"231_CR18","first-page":"15","volume":"114","author":"L Bogaert Van","year":"1966","unstructured":"Van Bogaert L, Van Damme J, Verschueren M. On a progressive syndrome of extrapyramidal hypertonia with gouty osteoarthropathies in 2 brothers. Rev Neurol (Paris). 1966;114:15\u201332.","journal-title":"Rev Neurol (Paris)"},{"key":"231_CR19","first-page":"103","volume":"24","author":"R Laplane","year":"1967","unstructured":"Laplane R, Polonovski C, Graveleau D. Congenital hyperuricemia in a cerebro-renal form. Arch Fr Pediatr. 1967;24:103\u20134.","journal-title":"Arch Fr Pediatr"},{"key":"231_CR20","first-page":"799","volume":"117","author":"C Polonovski","year":"1966","unstructured":"Polonovski C, et al. Encephalopathie et nephropathie metaboliques par hyperuricemie congenitale. Bull Mem Soc Med Hop Paris. 1966;117:799\u2013812.","journal-title":"Bull Mem Soc Med Hop Paris"},{"key":"231_CR21","first-page":"279","volume":"21","author":"WL Nyhan","year":"1978","unstructured":"Nyhan WL. Ataxia and disorders of purine metabolism: defects in hypoxanthine guanine phosphoribosyl transferase and clinical ataxia. Adv Neurol. 1978;21:279\u201387.","journal-title":"Adv Neurol"},{"key":"231_CR22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1383-5742(00)00052-1","volume":"463","author":"HA Jinnah","year":"2000","unstructured":"Jinnah HA, et al. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res. 2000;463:309\u201326.","journal-title":"Mutat Res"},{"key":"231_CR23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1081\/NCN-200027400","volume":"23","author":"HA Jinnah","year":"2004","unstructured":"Jinnah HA, et al. The spectrum of mutations causing HPRT deficiency: an update. Nucleos Nucleot Nucleic Acids. 2004;23:1153\u201360.","journal-title":"Nucleos Nucleot Nucleic Acids"},{"key":"231_CR24","first-page":"2513","volume-title":"The metabolic and molecular basis of inherited disease","author":"MA Becker","year":"2001","unstructured":"Becker MA. Hyperuricemia and gout. In: Scriver CR et al., editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill Book Company; 2001. p. 2513\u201335."},{"key":"231_CR25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1146\/annurev.bi.40.070171.004115","volume":"40","author":"AW Murray","year":"1971","unstructured":"Murray AW. The biological significance of purine salvage. Annu Rev Biochem. 1971;40:811\u201326.","journal-title":"Annu Rev Biochem"},{"key":"231_CR26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF01800725","volume":"12","author":"JE Seegmiller","year":"1989","unstructured":"Seegmiller JE. Contributions of Lesch-Nyhan syndrome to the understanding of purine metabolism. J Inherit Metab Dis. 1989;12:184\u201396.","journal-title":"J Inherit Metab Dis"},{"key":"231_CR27","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0021-9258(19)56968-X","volume":"243","author":"FM Rosenbloom","year":"1968","unstructured":"Rosenbloom FM, et al. Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem. 1968;243:1166\u201373.","journal-title":"J Biol Chem"},{"key":"231_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI108471","volume":"58","author":"S Brosh","year":"1976","unstructured":"Brosh S, et al. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. J Clin Invest. 1976;58:289\u201397.","journal-title":"J Clin Invest"},{"key":"231_CR29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI106316","volume":"49","author":"LB Sorensen","year":"1970","unstructured":"Sorensen LB. Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency. J Clin Invest. 1970;49:968\u201378.","journal-title":"J Clin Invest"},{"key":"231_CR30","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","volume":"120","author":"A So","year":"2010","unstructured":"So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120:1791\u20139.","journal-title":"J Clin Invest"},{"key":"231_CR31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237\u201341.","journal-title":"Nature"},{"key":"231_CR32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11926-011-0162-1","volume":"13","author":"F Ghaemi-Oskouie","year":"2011","unstructured":"Ghaemi-Oskouie F, Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep. 2011;13:160\u20136.","journal-title":"Curr Rheumatol Rep"},{"key":"231_CR33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.metabol.2007.04.013","volume":"56","author":"RJ Torres","year":"2007","unstructured":"Torres RJ, Prior C, Puig JG. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism. 2007;56:1179\u201386.","journal-title":"Metabolism"},{"key":"231_CR34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-62-4-639","volume":"62","author":"JR Klinenberg","year":"1965","unstructured":"Klinenberg JR, Goldfinger SE, Seegmiller JE. The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout. Ann Intern Med. 1965;62:639\u201347.","journal-title":"Ann Intern Med"},{"key":"231_CR35","first-page":"1084","volume":"67","author":"VM Pais","year":"2006","unstructured":"Pais VM, et al. Xanthine urolithiasis. Urol. 2006;67:1084. e9-1084.e11.","journal-title":"Urol"},{"key":"231_CR36","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00467-006-0149-8","volume":"21","author":"P Sikora","year":"2006","unstructured":"Sikora P, et al. Acute renal failure due to bilateral xanthine urolithiasis in a boy with Lesch-Nyhan syndrome. Pediatr Nephrol. 2006;21:1045\u20137.","journal-title":"Pediatr Nephrol"},{"key":"231_CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00240-011-0364-z","volume":"39","author":"MM Oh","year":"2011","unstructured":"\u2022 Oh MM, et al. Urine alkalinization may be enough for the treatment of bilateral renal pelvis stones associated with Lesch-Nyhan syndrome. Urol Res. 2011;39:417\u20139. This article describes a simple and noninvasive method of dissolving uric acid stones in LND.","journal-title":"Urol Res"},{"key":"231_CR38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000281067","volume":"40","author":"T Oka","year":"1985","unstructured":"Oka T, et al. Xanthine calculi in the patient with the Lesch-Nyhan syndrome associated with urinary tract infection. Urol Int. 1985;40:138\u201340.","journal-title":"Urol Int"},{"key":"231_CR39","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005;353:2450\u201361.","journal-title":"N Engl J Med"},{"key":"231_CR40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2008.09.011","volume":"53","author":"A Roche","year":"2009","unstructured":"\u2022 Roche A, et al. Efficacy of rasburicase in hyperuricemia secondary to Lesch-Nyhan syndrome. Am J Kidney Dis. 2009;53:677\u201380. This study describes the potential use of a novel therapy for particularly difficult patients with LND who have developed renal failure as a result of nephrolithiasis.","journal-title":"Am J Kidney Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0231-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-011-0231-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0231-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T23:33:02Z","timestamp":1640129582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-011-0231-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,24]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1007\/s11926-011-0231-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,24]]}}}